应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NTLA Intellia Therapeutics Inc
休市中 04-19 16:00:00 EDT
21.57
+0.25
+1.17%
盘后
21.57
+0.00
0.00%
19:54 EDT
最高
21.63
最低
20.78
成交量
145.72万
今开
21.22
昨收
21.32
日振幅
3.99%
总市值
20.80亿
流通市值
20.46亿
总股本
9,644万
成交额
3,105万
换手率
1.54%
流通股本
9,485万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报23.05美元
自选股智能写手 · 04-16
Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报23.05美元
Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报25.85美元
自选股智能写手 · 04-02
Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报25.85美元
Intellia Therapeutics, Inc.盘中异动 股价大跌5.20%报27.18美元
自选股智能写手 · 03-14
Intellia Therapeutics, Inc.盘中异动 股价大跌5.20%报27.18美元
Intellia Therapeutics, Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 03-06
Intellia Therapeutics, Inc.盘中异动 股价大跌5.00%
Intellia Therapeutics, Inc.盘中异动 股价大涨5.20%
自选股智能写手 · 03-01
Intellia Therapeutics, Inc.盘中异动 股价大涨5.20%
Intellia Therapeutics, Inc.盘中异动 早盘快速上涨5.00%
自选股智能写手 · 02-29
Intellia Therapeutics, Inc.盘中异动 早盘快速上涨5.00%
Intellia Therapeutics Inc2023财年实现净利润-4.81亿美元,同比减少1.48%
自选股智能写手 · 02-26
Intellia Therapeutics Inc2023财年实现净利润-4.81亿美元,同比减少1.48%
Intellia Therapeutics Inc盘中异动 早盘股价大跌5.04%报25.81美元
自选股智能写手 · 02-24
Intellia Therapeutics Inc盘中异动 早盘股价大跌5.04%报25.81美元
Intellia Therapeutics Inc盘中异动 大幅上涨5.03%报27.78美元
自选股智能写手 · 02-15
Intellia Therapeutics Inc盘中异动 大幅上涨5.03%报27.78美元
Intellia Therapeutics Inc盘中异动 急速上涨5.06%
自选股智能写手 · 02-10
Intellia Therapeutics Inc盘中异动 急速上涨5.06%
Intellia Therapeutics Inc盘中异动 股价大涨5.02%报25.02美元
自选股智能写手 · 02-02
Intellia Therapeutics Inc盘中异动 股价大涨5.02%报25.02美元
加载更多
公司概况
公司名称:
Intellia Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Intellia Therapeutics, Inc.于2014年5月在特拉华州注册成立。该公司是一家领先的基因编辑公司,专注于利用最近开发的被称为CRISPR/ Cas9的系统生物工具进行的独特的、潜在治愈疗法的发展。公司认为CRISPR/ Cas9技术具有通过单一疗程永久编辑疾病相关的基因在人体内进行改造药物的潜力。该公司打算利用其领先的科学专业知识、临床开发经验和知识产权地位解锁CRISPR/ Cas9基因编辑广泛的治疗应用,发展有潜能的新一代治疗产品。
发行价格:
--
{"stockData":{"symbol":"NTLA","market":"US","secType":"STK","nameCN":"Intellia Therapeutics Inc","latestPrice":21.57,"timestamp":1713556800000,"preClose":21.32,"halted":0,"volume":1457193,"hourTrading":{"tag":"盘后","latestPrice":21.57,"preClose":21.57,"latestTime":"19:54 EDT","volume":180728,"amount":3898313.3958,"timestamp":1713570873475},"delay":0,"floatShares":94852549,"shares":96438608,"eps":-5.42066,"marketStatus":"休市中","marketStatusCode":7,"change":0.25,"latestTime":"04-19 16:00:00 EDT","open":21.22,"high":21.63,"low":20.78,"amount":31050544.581552003,"amplitude":0.039869,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.42066,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"listingDate":1462507200000,"adjPreClose":21.32,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":21.051,"preClose":21.32,"latestTime":"09:29 EDT","volume":1032,"amount":21932.460288,"timestamp":1713533394165},"postHourTrading":{"tag":"盘后","latestPrice":21.57,"preClose":21.57,"latestTime":"19:54 EDT","volume":180728,"amount":3898313.3958,"timestamp":1713570873475},"volumeRatio":1.155022},"requestUrl":"/m/hq/s/NTLA","defaultTab":"news","newsList":[{"id":"2427188660","title":"Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报23.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427188660","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427188660?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:32","pubTimestamp":1713198756,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时32分,Intellia Therapeutics, Inc.股票出现异动,股价大幅下挫5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600323687e8080e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600323687e8080e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424049823","title":"Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报25.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424049823","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424049823?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:50","pubTimestamp":1712065815,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时50分,Intellia Therapeutics, Inc.股票出现波动,股价快速下挫5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.41%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022150157a50b693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022150157a50b693&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419986569","title":"Intellia Therapeutics, Inc.盘中异动 股价大跌5.20%报27.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419986569","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419986569?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:09","pubTimestamp":1710428998,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时09分,Intellia Therapeutics, Inc.股票出现异动,股价大幅跳水5.20%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.61%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031423095887e78f8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031423095887e78f8f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417425933","title":"Intellia Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417425933","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417425933?lang=zh_cn&edition=full","pubTime":"2024-03-06 03:10","pubTimestamp":1709665831,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日03时10分,Intellia Therapeutics, Inc.股票出现波动,股价快速跳水5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.48%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030603103179178cc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030603103179178cc2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416600642","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416600642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416600642?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:21","pubTimestamp":1709306485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时21分,Intellia Therapeutics, Inc.股票出现异动,股价快速上涨5.20%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.76%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012321257a48980e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012321257a48980e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415552941","title":"Intellia Therapeutics, Inc.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415552941","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415552941?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:48","pubTimestamp":1709218089,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时48分,Intellia Therapeutics, Inc.股票出现异动,股价大幅上涨5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.17%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922480987e74e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922480987e74e76&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414992650","title":"Intellia Therapeutics Inc2023财年实现净利润-4.81亿美元,同比减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414992650","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414992650?lang=zh_cn&edition=full","pubTime":"2024-02-26 00:21","pubTimestamp":1708878062,"startTime":"0","endTime":"0","summary":"12月31日,Intellia Therapeutics Inc公布财报,公告显示公司2023财年净利润为-4.81亿美元,同比减少1.48%;其中营业收入为36.28百万美元,同比减少30.39%,每股基本收益为-5.42美元。从资产负债表来看,Intellia Therapeutics Inc总负债2.51亿美元,其中短期债务18.60百万美元,资产负债比为5.19,流动比率为8.68。机构评级:截至2023年12月31日,当前有23家机构对Intellia Therapeutics Inc目标价做出预测,其中目标均价为68.74美元,其中最低目标价为24.00美元,最高目标价为144.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600210681b6075a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600210681b6075a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413795485","title":"Intellia Therapeutics Inc盘中异动 早盘股价大跌5.04%报25.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413795485","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413795485?lang=zh_cn&edition=full","pubTime":"2024-02-24 00:14","pubTimestamp":1708704846,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日00时14分,Intellia Therapeutics Inc股票出现异动,股价大幅下挫5.04%。Intellia Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.56%。Intellia Therapeutics Inc公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240224001406861d7f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240224001406861d7f32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411813465","title":"Intellia Therapeutics Inc盘中异动 大幅上涨5.03%报27.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411813465","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411813465?lang=zh_cn&edition=full","pubTime":"2024-02-15 00:54","pubTimestamp":1707929666,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日00时54分,Intellia Therapeutics Inc股票出现波动,股价急速上涨5.03%。Intellia Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.54%。Intellia Therapeutics Inc公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215005426861d540b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215005426861d540b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410806164","title":"Intellia Therapeutics Inc盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410806164","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410806164?lang=zh_cn&edition=full","pubTime":"2024-02-10 02:28","pubTimestamp":1707503286,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日02时28分,Intellia Therapeutics Inc股票出现波动,股价快速上涨5.06%。Intellia Therapeutics Inc股票所在的生物技术行业中,整体涨幅为1.08%。Intellia Therapeutics Inc公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021002280779109d65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021002280779109d65&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408652051","title":"Intellia Therapeutics Inc盘中异动 股价大涨5.02%报25.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408652051","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408652051?lang=zh_cn&edition=full","pubTime":"2024-02-02 01:55","pubTimestamp":1706810135,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日01时55分,Intellia Therapeutics Inc股票出现波动,股价快速拉升5.02%。Intellia Therapeutics Inc股票所在的生物技术行业中,整体涨幅为1.09%。Intellia Therapeutics Inc公司简介:Intellia Therapeutics是一家专注于开发基于CRISPR/ cas9的治疗方法的基因编辑公司。Intellia专注于使用这项技术来治疗基因定义的疾病。Intellia已经与几家公司建立了合作关系,以推进其产品线,包括窄护城河Regeneron和宽护城河Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020201553687e6b3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020201553687e6b3ac&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intelliatx.com","stockEarnings":[{"period":"1week","weight":-0.1475},{"period":"1month","weight":-0.2284},{"period":"3month","weight":-0.1656},{"period":"6month","weight":-0.1997},{"period":"1year","weight":-0.4339},{"period":"ytd","weight":-0.3008}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Intellia Therapeutics, Inc.于2014年5月在特拉华州注册成立。该公司是一家领先的基因编辑公司,专注于利用最近开发的被称为CRISPR/ Cas9的系统生物工具进行的独特的、潜在治愈疗法的发展。公司认为CRISPR/ Cas9技术具有通过单一疗程永久编辑疾病相关的基因在人体内进行改造药物的潜力。该公司打算利用其领先的科学专业知识、临床开发经验和知识产权地位解锁CRISPR/ Cas9基因编辑广泛的治疗应用,发展有潜能的新一代治疗产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.014871},{"month":2,"riseRate":0.75,"avgChangeRate":0.078068},{"month":3,"riseRate":0.25,"avgChangeRate":-0.040105},{"month":4,"riseRate":0.375,"avgChangeRate":-0.074459},{"month":5,"riseRate":0.285714,"avgChangeRate":0.035262},{"month":6,"riseRate":0.875,"avgChangeRate":0.235553},{"month":7,"riseRate":0.5,"avgChangeRate":0.003735},{"month":8,"riseRate":0.625,"avgChangeRate":0.047366},{"month":9,"riseRate":0.125,"avgChangeRate":-0.068112},{"month":10,"riseRate":0.25,"avgChangeRate":-0.059832},{"month":11,"riseRate":0.625,"avgChangeRate":0.121561},{"month":12,"riseRate":0.375,"avgChangeRate":-0.073139}],"exchange":"NASDAQ","name":"Intellia Therapeutics Inc","nameEN":"Intellia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intellia Therapeutics Inc(NTLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Intellia Therapeutics Inc(NTLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Intellia Therapeutics Inc,NTLA,Intellia Therapeutics Inc股票,Intellia Therapeutics Inc股票老虎,Intellia Therapeutics Inc股票老虎国际,Intellia Therapeutics Inc行情,Intellia Therapeutics Inc股票行情,Intellia Therapeutics Inc股价,Intellia Therapeutics Inc股市,Intellia Therapeutics Inc股票价格,Intellia Therapeutics Inc股票交易,Intellia Therapeutics Inc股票购买,Intellia Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intellia Therapeutics Inc(NTLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Intellia Therapeutics Inc(NTLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}